Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GALT | GALECTIN THERAPEUTICS INC | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
PLX | Protalix BioTherapeutics, Inc. | Director | Sep 29, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|